Trading / Browse Companies / Prosetta Biosciences Stock

Prosetta Biosciences Stock

prosetta.comHealthcareFounded: 2003Funding to Date: $40.04MM

Prosetta Biosciences is a biotechnology company focused on developing novel small-molecule antiviral therapeutics based on Cell-Free Protein Synthesizing Systems (CFPSS).

Buy or sell Prosetta Biosciences stockLearn more about Prosetta Biosciences IPO
Register for Details

For more details on financing and valuation for Prosetta Biosciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Prosetta Biosciences.

Register Today

Team

Management Team

Karl Manheim
Co-Founder & Board Member
Vishwanath Lingappa Ph.D
Co-Founder, Board Member, Chief Technology Officer & Chief Executive Officer
Thomas Higgins
Founding Chief Executive & Chairman

Board Members

CJ Sylvester
Fred Alger Management
Vishwanath Lingappa Ph.D
Dale Bredesen MD
Karl Manheim
Charles Parrish
David Keys
Thomas Higgins

Other companies like Prosetta Biosciences in the Healthcare sector

Neuralink
Sector
Healthcare
Last Round Est. Valuation
$2.15B
Altos Labs
Sector
Healthcare
Last Round Est. Valuation
$3.67B
OURA
Sector
Healthcare
 
 
Headspace
Sector
Healthcare
Last Round Est. Valuation
$317.32MM
NowRx
Sector
Healthcare
Last Round Est. Valuation
$334.19MM
Mammoth Biosciences
Sector
Healthcare
Last Round Est. Valuation
$1.08B
GoForward
Sector
Healthcare
Last Round Est. Valuation
$1.59B
Grail
Sector
Healthcare
Last Round Est. Valuation
$4.26B
VillageMD
Sector
Healthcare
 
 

News

PRNewswire 03/28/2017
Purch Expands Industry-Leading Yield Optimization Platform
NEW YORK, March 28, 2017 /PRNewswire/ -- Purch, a digital publishing and marketplace platform, announced today that...

Trending Companies

Frequently Asked Questions